Erik M.

Erik M. possesses extensive experience in global regulatory affairs with a focus on vaccines. Currently serving as the Executive Director of Global Regulatory Affairs - CMC Vaccines at Merck, Erik has previously held significant positions at Sanofi, including Head of Global Regulatory Affairs CMC - Vaccines - Influenza and Senior Director, Global Project Head for late-stage R&D projects. Other roles at Sanofi involved directing global regulatory affairs for the Influenza/RSV franchise and heading global regulatory affairs labeling. Prior to Sanofi, Erik was with GlaxoSmithKline as Director of Regulatory Affairs Policy for vaccines and managed US Regulatory Affairs, CMC at Teva Pharmaceuticals. Erik holds a Master of Business Administration from Saint Joseph's University and a degree from Muhlenberg College.